Literature DB >> 21338464

Intestinal microbiota, evolution of the immune system and the bad reputation of pro-inflammatory immunity.

Caspar Ohnmacht1, Rute Marques, Laura Presley, Shinichiro Sawa, Matthias Lochner, Gérard Eberl.   

Abstract

The mammalian intestine provides a unique niche for a large community of bacterial symbionts that complements the host in digestive and anabolic pathways, as well as in protection from pathogens. Only a few bacterial phyla have adapted to this predominantly anaerobic environment, but hundreds of different species create an ecosystem that affects many facets of the host's physiology. Recent data show how particular symbionts are involved in the maturation of the immune system, in the intestine and beyond, and how dysbiosis, or alteration of that community, can deregulate immunity and lead to immunopathology. The extensive and dynamic interactions between the symbionts and the immune system are key to homeostasis and health, and require all the blends of so-called regulatory and pro-inflammatory immune reactions. Unfortunately, pro-inflammatory immunity leading to the generation of Th17 cells has been mainly associated with its role in immunopathology. Here we discuss the view that the immune system in general, and type 17 immunity in particular, develop to maintain the equilibrium of the host with its symbionts.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21338464     DOI: 10.1111/j.1462-5822.2011.01577.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  25 in total

Review 1.  Human microbiota, blood group antigens, and disease.

Authors:  D Rose Ewald; Susan C J Sumner
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-01-09

Review 2.  The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin.

Authors:  Casey T Weaver; Charles O Elson; Lynette A Fouser; Jay K Kolls
Journal:  Annu Rev Pathol       Date:  2012-11-15       Impact factor: 23.472

Review 3.  Recent progress in mucosal vaccine development: potential and limitations.

Authors:  Nils Lycke
Journal:  Nat Rev Immunol       Date:  2012-07-25       Impact factor: 53.106

Review 4.  Role of the microbiota in immunity and inflammation.

Authors:  Yasmine Belkaid; Timothy W Hand
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

Review 5.  Intestinal barrier: A gentlemen's agreement between microbiota and immunity.

Authors:  Andrea Moro Caricilli; Angela Castoldi; Niels Olsen Saraiva Câmara
Journal:  World J Gastrointest Pathophysiol       Date:  2014-02-15

6.  Commensal Propionibacterium strain UF1 mitigates intestinal inflammation via Th17 cell regulation.

Authors:  Natacha Colliou; Yong Ge; Bikash Sahay; Minghao Gong; Mojgan Zadeh; Jennifer L Owen; Josef Neu; William G Farmerie; Francis Alonzo; Ken Liu; Dean P Jones; Shuzhao Li; Mansour Mohamadzadeh
Journal:  J Clin Invest       Date:  2017-09-25       Impact factor: 14.808

7.  Sensing of mammalian IL-17A regulates fungal adaptation and virulence.

Authors:  Teresa Zelante; Rossana G Iannitti; Antonella De Luca; Javier Arroyo; Noelia Blanco; Giuseppe Servillo; Dominique Sanglard; Utz Reichard; Glen E Palmer; Jean-Paul Latgè; Paolo Puccetti; Luigina Romani
Journal:  Nat Commun       Date:  2012-02-21       Impact factor: 14.919

Review 8.  Inflammation and colorectal cancer, when microbiota-host mutualism breaks.

Authors:  Marco Candela; Silvia Turroni; Elena Biagi; Franck Carbonero; Simone Rampelli; Carla Fiorentini; Patrizia Brigidi
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

9.  Allergies and Asthma: Do Atopic Disorders Result from Inadequate Immune Homeostasis arising from Infant Gut Dysbiosis?

Authors:  Christine C Johnson; Dennis R Ownby
Journal:  Expert Rev Clin Immunol       Date:  2016-02-07       Impact factor: 4.473

10.  Regulatory T cells promote a protective Th17-associated immune response to intestinal bacterial infection with C. rodentium.

Authors:  Z Wang; C Friedrich; S C Hagemann; W H Korte; N Goharani; S Cording; G Eberl; T Sparwasser; M Lochner
Journal:  Mucosal Immunol       Date:  2014-03-19       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.